Jules Bordet Institute | Articles scientifiques

Prophylaxis of febrile neutropenia in adults receiving chemotherapy needs to be adapted to the risk.

Authors : Georgala A, Klastersky J
Year : 2015
Journal : Expert Rev Hematol
Volume : 8(1)
Pages : 115-21

Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?

Authors : Latifyan SB, Vanhaeverbeek M, Klastersky J
Year : 2014
Journal : BMJ Case Rep
Volume : 2014(null)

Strategies for the empirical management of infection in cancer patients with emphasis on the emergence of resistant gram-negative bacteria.

Authors : Klastersky J, Georgala A
Year : 2014
Journal : Crit Rev Oncol Hematol
Volume : 92(3)
Pages : 266-78

Febrile Neutropenia in pocket Books for Cancer Supportive Care (2014), Springer Healthcare

Authors : Klastersky J
Year : 2014
Journal : Book
Volume : -
Pages : -

Adverse events of targeted therapies.

Authors : Klastersky J
Year : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pages : 395-402

Supportive care is a constant state of changing: we need to adjust for it.

Authors : Klastersky J
Year : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pages : 371

The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.

Authors : Klastersky J, Paesmans M
Year : 2013
Journal : Support Care Cancer
Volume : 21(5)
Pages : 1487-95

The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia.

Authors : Klastersky J, Raftopoulos H, Rapoport B
Year : 2013
Journal : Support Care Cancer
Volume : 21(6)
Pages : 1793-5

Supportive care in cancer patients: a unifying concept.

Authors : Klastersky J
Year : 2013
Journal : Curr Opin Oncol
Volume : 25(4)
Pages : 341

Histiocytose agressive à cellules de Langerhans 20 ans après un cancer du sein : à propos d’un cas.

Authors : Zakkouri F, Klastersky J, Alexiou J, de Saint-Aubain de Somerhausen N, Flamen P, Firescu R, Georgala A, Awada A
Year : 2013
Journal : J Am Soc Echocardiogr
Volume : 5
Pages : 220-223

Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC).

Authors : Klastersky J, Awada A
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 81(1)
Pages : 49-57

Význam biomarkerù v klinické onkologii

Authors : Klastersky J
Year : 2012
Journal : lekarsky Sbornik
Volume : sup1
Pages : 14-17

Are there several kinds of palliative care?

Authors : Klastersky J
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(4)
Pages : 355-6

Prévention et traitement des infections. (TEXTBOOK : « Thérapeutique du cancer » Morère JF, Mornex F., Soulières D. 2ème édition. Springer-Verlag, Paris, France)

Authors : Klastersky J, Aoun M
Year : 2011
Journal : Book
Volume : -
Pages : 151-65

Supportive care for patients with gynaecological cancer

Authors : Klastersky J, Lossignol D
Year : 2011
Journal : South Afr Gynaecol Oncol
Volume : 3
Pages : 9-12

Prevention of febrile neutropenia in chemotherapy – treated cancer patients : Pegylated versus standard myeloid colony stimulating factors. Do we have a choice ?

Authors : Klastersky J, Awada A
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(1)
Pages : 17-23

Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?